Us2.ai
FDA-cleared AI echocardiography platform that automates measurements, disease-detection support, and structured reporting from DICOM echo studies.
Last updated: June 14, 2026
Back to directoryFDA-cleared echocardiography AI that analyzes apical four-chamber clips to support detection of heart failure with preserved ejection fraction.
Heart-failure and echo programs evaluating structured AI support for HFpEF workups in clinician-reviewed workflows.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
| Status | FDA-cleared EchoGo Heart Failure 2.0 adjunctive heart-failure status indicator software. |
|---|---|
| Review route | 510(k) K240013. |
| Intended use | Analyzes non-contrast echocardiograms with at least one full cardiac cycle and is used by an interpreting clinician as an aid to HFpEF diagnosis; the final diagnosis remains the clinician's responsibility. |
| Verification note | Confirm the deployed EchoGo version, input echo requirements, image-quality handling, eligible clinical workflow, reimbursement use, report integration, and clinician review policy. |
| Source | www.accessdata.fda.gov / cdrh_docs / pdf24 |
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Ultromics EchoGo as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Match the EchoGo Heart Failure version, 510(k) record, indication, product code, geography, and reimbursement workflow before using output in a heart-failure pathway. |
|---|---|
| Privacy | Review echocardiography upload flow, cloud or integration partner processing, customer-controller obligations, retention, deletion, access controls, DPO contact path, and support-data handling. |
| Evidence | Evaluate HFpEF detection evidence, eligible echo views, image-quality failures, false-positive and false-negative burden, patient population fit, and downstream testing or referral impact. |
| Workflow | Best governed as cardiologist-reviewed echo decision support that feeds HFpEF diagnostic workups, structured reporting, and follow-up planning rather than autonomous diagnosis. |
Ultromics describes EchoGo Heart Failure as an FDA-cleared AI-enabled medical device and diagnostic aid for HFpEF detection from echocardiography; FDA records list EchoGo Heart Failure 510(k) clearances, and Ultromics privacy materials describe customer-controlled patient-data processing and EchoGo retention terms.
Not for: Standalone heart-failure diagnosis, unsupported echo views, or use outside the cleared indication, product version, and physician-review workflow.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.